FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Apr 21, 2010
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on April 21, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA Inc
- Inspection Date
- April 21, 2010
- Product Type
- Biologics
View Company Profile
ID · d5cd9819-4dff-402d-adc5-0adc166c3de0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 660339
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
5- 21 CFR 606.160(b)Required records
- 21 CFR 630.40(a)Notification
- 21 CFR 630.40(a)Supplemental results
- 21 CFR 606.65(e)Following manufacturer"s instructions
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 22, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 13, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 27, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 28, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 1342976 - 2026-10-22
- FDA Inspection 1249577 - 2024-09-13
- FDA Inspection 1060167 - 2018-07-27
- FDA Inspection 863406 - 2014-01-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.